Advanced SearchSearch Tips
Differential Expression of O-glycoprotein Glycans in Cholangiocarcinoma Cell Lines
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Differential Expression of O-glycoprotein Glycans in Cholangiocarcinoma Cell Lines
Talabnin, Krajang; Talabnin, Chutima; Ishihara, Mayumi; Azadi, Parastoo; Wongkham, Sopit; Sripa, Banchob;
  PDF(new window)
Protein glycosylation is the most common posttranslational modification in mammalian cells. Aberrant protein glycosylation has been reported in various diseases, including cancer. We identified and quantified the glycan structures of O-linked glycoprotein from cholangiocarcinoma (CCA) cell lines from different histological types and compared their profiles by nanospray ionization-linear ion trap mass spectrometry (NSI-). Five human CCA cell lines, K100, M055, M139, M213 and M214 were characterized. The results showed that the O-linked glycans of the CCA cell lines comprised tri- to hexa-saccharides with terminal galactose and sialic acids: NeuAc1Gal1GalNAc1, Gal2GlcNAc1GalNAc1, NeuAc2Gal1GalNAc1 NeuAc1Gal2GlcNAc1GalNAc1 and NeuAc2Gal2GlcNAc1GalNAc1 All five CCA cell lines showed a similar glycan pattern, but with differences in their quantities. NeuAc1Gal1GalNAc1 proved to be the most abundant structure in poorly differentiated adenocarcinoma (K100; 57.1%), moderately differentiated adenocarcinoma (M055; 42.6%) and squamous cell carcinoma (M139; 43.0%), while moderately to poorly differentiated adenocarcinoma (M214; 40.1%) and adenosquamous cell carcinoma (M213; 34.7%) appeared dominated by . These results demonstrate differential expression of the O-linked glycans in the different histological types of CCA. All five CCA cell lines have abundant terminal sialic acid (NeuAc) O-linked glycans, suggesting an important role for sialic acid in cancer cells. Our structural analyses of glycans may provide important information regarding physiology of disease-related glycoproteins in CCA.
Cholangiocarcinoma;glycoprotein;O-linked glycans;sialic acid;
 Cited by
Mass spectrometry for protein sialoglycosylation, Mass Spectrometry Reviews, 2017, 02777037  crossref(new windwow)
Anumula KR, Taylor PB (1992). A comprehensive procedure for preparation of partially methylated alditol acetates from glycoprotein carbohydrates. Anal Biochem, 203, 101-8. crossref(new window)

Aoki K, Perlman M, Lim JM, et al (2007). Dynamic developmental elaboration of N-linked glycan complexity in the Drosophila melanogaster embryo. J Biol Chem, 282, 9127-42. crossref(new window)

Aoki K, Porterfield M, Lee SS, et al (2008). The diversity of O-linked glycans expressed during Drosophila melanogaster development reflects stage- and tissue-specific requirements for cell signaling. J Biol Chem, 283, 30385-400. crossref(new window)

Apweiler R, Hermjakob H, Sharon N (1999). On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochimica Et Biophysica Acta, 1473, 4-8. crossref(new window)

Brockhausen I, Yang JM, Burchell J, et al (1995). Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur J Biochem, 233, 607-17. crossref(new window)

Bull C, Stoel MA, den Brok MH, et al (2014). Sialic acids sweeten a tumor's life. Cancer Res, 74, 3199-204. crossref(new window)

Burchell J, Poulsom R, Hanby A, et al (1999). An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiol, 9, 1307-11. crossref(new window)

Chik JH, Zhou J, Moh ES, et al (2014). Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies. J Proteomics, 108, 146-62. crossref(new window)

Domon B, Costello CE (1988). Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. Biochemistry, 27, 1534-43. crossref(new window)

Indramanee S, Silsirivanit A, Pairojkul C, et al (2012). Aberrant glycosylation in cholangiocarcinoma demonstrated by lectinhistochemistry. Asian Pac J Cancer Prev, 13, 119-24.

Juntavee A, Sripa B, Pugkhem A, et al (2005). Expression of sialyl Lewis(a) relates to poor prognosis in cholangiocarcinoma. World J Gastroenterol, 11, 249-54. crossref(new window)

Kim EH, Misek DE (2011). Glycoproteomics-based identification of cancer biomarkers. Int J Proteomics, 2011, 601937.

Patel T (2001). Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatol, 33, 1353-7. crossref(new window)

Phoomak C, Silsirivanit A, Wongkham C, et al (2012). Overexpression of O-GlcNAc-transferase associates with aggressiveness of mass-forming cholangiocarcinoma. Asian Pac J Cancer Prev, 13, 101-5.

Sawanyawisuth K, Silsirivanit A, Kunlabut K, et al (2012). A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis. Parasitology Int, 61, 151-4. crossref(new window)

Shaib YH, Davila JA, McGlynn K, et al (2004). Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol, 40, 472-7. crossref(new window)

Silsirivanit A, Araki N, Wongkham C, et al (2011). A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma. Cancer, 117, 3393-403. crossref(new window)

Silsirivanit A, Araki N, Wongkham C, et al (2013). CA-S27: a novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma. Cancer Sci, 104, 1278-84. crossref(new window)

Wong CH (2005). Protein glycosylation: new challenges and opportunities. J Organic Chemistry, 70, 4219-25. crossref(new window)